iHuman Inc is an education & training services business based in the US. iHuman shares (IH) are listed on the NYSE and all prices are listed in US Dollars. iHuman employs 817 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Guided Investing
Our top pick for
Experienced Investors
| Latest market close | $5.05 |
|---|---|
| 52-week range | $4.30 - $30.00 |
| 50-day moving average | $5.83 |
| 200-day moving average | $9.17 |
| Wall St. target price | $8.80 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.12 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.05 from 2021-10-15
| 1 week (2021-10-08) | 3.70% |
|---|---|
| 1 month (2021-09-16) | -2.13% |
| 3 months (2021-07-16) | -50.15% |
| 6 months (2021-04-16) | -58.37% |
| 1 year (2020-10-16) | -79.62% |
|---|---|
| 2 years (2019-10-12) | N/A |
| 3 years (2018-10-12) | N/A |
| 5 years (2016-10-12) | N/A |
Valuing iHuman stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iHuman's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iHuman's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2 million.
The EBITDA is a measure of a iHuman's overall financial performance and is widely used to measure a its profitability.
To put iHuman's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $794.4 million |
|---|---|
| Gross profit TTM | $365.4 million |
| Return on assets TTM | -4.34% |
| Return on equity TTM | -13.09% |
| Profit margin | -4.29% |
| Book value | $12.32 |
| Market capitalisation | $259.7 million |
TTM: trailing 12 months
There are currently 81,988 iHuman shares held short by investors – that's known as iHuman's "short interest". This figure is 7.7% down from 88,855 last month.
There are a few different ways that this level of interest in shorting iHuman shares can be evaluated.
iHuman's "short interest ratio" (SIR) is the quantity of iHuman shares currently shorted divided by the average quantity of iHuman shares traded daily (recently around 28767.719298246). iHuman's SIR currently stands at 2.85. In other words for every 100,000 iHuman shares traded daily on the market, roughly 2850 shares are currently held short.
To gain some more context, you can compare iHuman's short interest ratio against those of similar companies.
However iHuman's short interest can also be evaluated against the total number of iHuman shares, or, against the total number of tradable iHuman shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iHuman's short interest could be expressed as 0% of the outstanding shares (for every 100,000 iHuman shares in existence, roughly 0 shares are currently held short) or 0.0057% of the tradable shares (for every 100,000 tradable iHuman shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iHuman.
Find out more about how you can short iHuman stock.
We're not expecting iHuman to pay a dividend over the next 12 months.
You may also wish to consider:
iHuman Inc. provides childhood edutainment products and services to individual users, education organizations, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman English, iHuman Pinyin, iHuman Magic Math, iHuman Books, and iHuman Stories. It also provides learning materials in physical and digital formats; and learning devices. The company was founded in 1996 and is based in Beijing, the People's Republic of China. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.